Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
10/2001
10/04/2001EP1138677A1 Process for the preparation of 11-amino-3-chloro-6,11-dihydro-5,5-dioxo-6-methyl-dibenzo[c,f][1,2]-thiazepine and application to the synthesis of tianeptine
10/04/2001EP1138673A2 Novel carbamates and ureas as modifiers of multi-drug resistance
10/04/2001EP1138334A2 Pretargeting methods and compounds
10/04/2001EP1138330A1 Combination of trimebutine with an opioid analgesic
10/04/2001EP1138329A2 Composition containing 5-Methyl-1-phenyl-2-(1 H)-pyridone for reparation and prevention of fibrotic lesions
10/04/2001EP1138328A1 Naphthalene derivatives as CNS drugs
10/04/2001EP1137806A1 Detection of rantes gene promoter polymorphisms
10/04/2001EP1137805A1 Methods of facilitating vascular growth
10/04/2001EP1137793A2 Novel nucleic acid transferring agents, compositions containing them and uses
10/04/2001EP1137780A1 Therapeutic and diagnostic uses of protein tyrosine phosphatase tc-ptp
10/04/2001EP1137771A2 Methods for preventing cardiac hypertrophy and heart failure by inhibition of mef2 transcription factor
10/04/2001EP1137764A1 New medical use of gene and vector encoding a multisubstrate deoxyribonucleosidase
10/04/2001EP1137762A1 Treatment of pompe's disease
10/04/2001EP1137667A2 Analogues of glp-1
10/04/2001EP1137665A1 Cark protein and nucleic acid molecules and uses therefor
10/04/2001EP1137664A2 Protein transduction system and methods of use thereof
10/04/2001EP1137662A1 Pharmaceutical compositions comprising quinapril magnesium
10/04/2001EP1137661A1 Procollagen c-proteinase inhibitors
10/04/2001EP1137659A1 Inhibition of angiogenesis by high molecular weight kininogen and peptide analogs thereof
10/04/2001EP1137640A1 Cyclic hydrazine derivatives as tnf-alpha inhibitors
10/04/2001EP1137638A2 Isoquinoline derivatives
10/04/2001EP1137637A1 N-(2-phenyl-4-piperidinylbutyl)-5,6,7,8-tetrahydro-1-naphthalenecarboxamides and their use as neurokinin 1 (nk1) and/or neurokinin 2 (nk2) receptor antagonists
10/04/2001EP1137635A1 N-substituted 2-cyanopyrrolidines
10/04/2001EP1137621A1 Aldose reductase inhibitors and pharmaceutical compositions
10/04/2001EP1137497A1 Apparatus for separating particles of cohesive material according to size and process
10/04/2001EP1137433A2 Pharmaceutical compositions containing protein-disulfide isomerases
10/04/2001EP1137429A2 Bioflavonoids, anthocyanins and phenolic compounds from cherries for inhibiting inflammation
10/04/2001EP1137427A1 Cancer treatment composition and method using natural plant essential oils with signal transduction modulators
10/04/2001EP1137426A1 Cancer treatment composition and method using natural plant essential oils
10/04/2001EP1137425A1 Cancer treatment composition and method using signal transduction modulators and natural plant essential oils
10/04/2001EP1137419A1 Uses of 1-amino-3-(n,n-dimethylamino)-propylidene-1,1-bisphosphonic acid
10/04/2001EP1137418A2 METHODS AND COMPOSITIONS FOR RESTORING CONFORMATIONAL STABILITY OF A PROTEIN OF THE p53 FAMILY
10/04/2001EP1137415A1 Myt1 kinase inhibitors
10/04/2001EP1137413A2 Non-peptide antagonists of glp-1 receptor and methods of use
10/04/2001EP1137410A1 Novel 4-dedimethy laminotetra cycline derivatives
10/04/2001EP1137408A1 Agent for lowering endothelin levels
10/04/2001EP1123094A4 Therapeutic compositions (ii)
10/04/2001EP1079852B1 Composition based on pentoxifylline and anticytokin
10/04/2001EP0975631B1 5-aryl-3-(8-azabicyclo[3.2.1]oct-3-yl)-1,3,4-oxadiazol-2(3h)-one derivatives as 5-ht4 receptor ligands
10/04/2001EP0880528B1 Spiro-ketal derivatives and their use as therapeutic agents
10/04/2001EP0874841B1 1-benzenesulfonyl pyrrolidine derivatives as bradykinin receptor antagonists
10/04/2001EP0855999B1 1-(1,2-disubstituted piperidinyl)-4-substituted piperidine derivatives as tachykinin receptor antagonists
10/04/2001EP0828726B1 Tricyclic inhibitors of matrix metalloproteinases
10/04/2001EP0821665B1 Cyclobutane derivatives as inhibitors of squalene synthase and protein farnesyltransferase
10/04/2001EP0815123B1 Beta-sheet mimetics and use thereof as protease inhibitors
10/04/2001EP0815105B1 Heterocyclic substituted piperazinone derivatives as tachykinin receptor antagonists
10/04/2001EP0802909B1 Substituted oxazolidine calpain and/or cathepsin b inhibitors
10/04/2001EP0802796B1 Chicken anaemia agent broiler vaccine
10/04/2001EP0688314B1 Prodrug derivatives of enzyme inhibitors with hydroxyl groups, methods of preparing them and their use
10/04/2001EP0639979B1 LIGAND FOR THE c-KIT RECEPTOR AND METHODS OF USE THEREOF
10/04/2001EP0613465B1 1,3-substituted cycloalkenes and cycloalkanes as central nervous system agents
10/04/2001EP0606463B1 Neuromedin b receptor antagonists
10/04/2001EP0552329B1 Methylen-oxindole derivatives and process for their preparation
10/04/2001DE19947154A1 Substituierte 2-Thio-3,5-dicyano-4-aryl-6-aminopyridine und ihre Verwendung Substituted 2-thio-3,5-dicyano-4-aryl-6-aminopyridines and their use
10/04/2001CA2659030A1 Methods for inhibiting angiogenesis and tumor growth
10/04/2001CA2429196A1 Characterization of grp94-ligand interactions and purification, screening, and therapeutic methods relating thereto
10/04/2001CA2405502A1 Method of treating hepatitis delta viral infection
10/04/2001CA2404901A1 Composition and method for intervening neuronal death using sulfasalazine
10/04/2001CA2404780A1 Targeted chromosomal genomic alterations with modified single stranded oligonucleotides
10/04/2001CA2404712A1 Synergistic methods and compositions for treating cancer comprising antiproliferative cytotoxic and cytostatic agents
10/04/2001CA2404669A1 Condensed pyrazole derivatives, process for producing the same and use thereof
10/04/2001CA2404662A1 3-cyanoquinolines,3-cyano-1,6-naphthyridines, and 3-cyano-1,7-naphthyridines as protein kinase inhibitors
10/04/2001CA2404626A1 Novel piperazine derivatives
10/04/2001CA2404574A1 Isolated human g-protein coupled receptors that are members of the aminergic subfamily, nucleic acid molecules encoding human gpcr proteins, and uses thereof
10/04/2001CA2404532A1 Method of identifying inhibitors of tie-2
10/04/2001CA2404511A1 Tlr/cd14 binding inhibitor
10/04/2001CA2404474A1 Prodrugs of imidazopyridine derivatives
10/04/2001CA2404461A1 Human g-protein coupled receptors
10/04/2001CA2404445A1 Tricyclic protein kinase inhibitors
10/04/2001CA2404439A1 Diphenyl ether compounds useful in therapy
10/04/2001CA2404157A1 Inhibition of a novel calcium injury current that forms in neurons during injury prevents neuronal cell death
10/04/2001CA2404060A1 Methods of treating neoplasia with combinations of target cell-specific adenovirus, chemotherapy and radiation
10/04/2001CA2404049A1 Treatment of movement disorders
10/04/2001CA2403857A1 Anti-angiogenic and anti-tumor properties of matin and other laminin domains
10/04/2001CA2403814A1 Polyamine analogues as cytotoxic agents
10/04/2001CA2403800A1 Beta-like glycoprotein hormone polypeptide and heterodimer
10/04/2001CA2403787A1 Il-8 receptor antagonists
10/04/2001CA2403515A1 Anti-angiogenic and anti-tumor properties of vascostatin and other nidogen domains
10/04/2001CA2402780A1 Insulin and igf-1 receptor agonists and antagonists
10/04/2001CA2402613A1 Cationic liposomes
10/04/2001CA2402472A1 2,3,4,5-tetrahydro-1h-¬1,4|diazepino¬1,7a|indole compounds
10/04/2001CA2402288A1 Naphtalene derivatives and their pharmaceutical use
10/04/2001CA2402187A1 Intracorporeal medicaments comprising halogenated xanthene for photodynamic treatment of disease
10/04/2001CA2401748A1 2-substituted 4-heteroaryl-pyrimidines and their use in the treatment of proliferative disorders
10/04/2001CA2401242A1 Pharmaceutically active pyrrolidine derivatives
10/04/2001CA2401120A1 Lactams as inhibitors of a-beta protein production
10/04/2001CA2400573A1 Alteration of cellular behavior by antisense modulation of mrna processing
10/04/2001CA2399864A1 4-amino-5-cyano-2-anilino-pyrimidine derivatives and their use as inhibitors of cell-cycle kinases
10/04/2001CA2374911A1 G-protein coupled receptors
10/03/2001CN1315965A Hepatitis C inhibitor peptides
10/03/2001CN1315950A Dihydrobenzodioxine carboxamide and ketone derivatives as 5-HT4 receptor antagonists
10/03/2001CN1315949A Salts of paroxetine
10/03/2001CN1315942A 2-oxo-j(2H)-quinoline derivatives
10/03/2001CN1315873A Prevention/remedies for multiple organ failure
10/03/2001CN1315869A Artificial T helper cell epitopes as immune stimulators for synthetic peptide immunogens including immunogenic LHRH peptides
10/03/2001CN1315868A Pharmaceutical formulations for IGF/IGFBP
10/03/2001CN1315865A Stabilized pharmaceutical Composition in lyophilized form
10/03/2001CN1315864A Powdery preparation for mucosal administration containing polymeric medicine
10/03/2001CN1315863A Use of rosmarinic acid and derivatives thereof as immunosuppressant or inhibitor of SHz-mediated process
10/03/2001CN1315856A Therapeutic methods employing disulfide derivatives of dithiocarbamates and compositions useful therefor
1 ... 1023 1024 1025 1026 1027 1028 1029 1030 1031 1032 1033 1034 1035 1036 1037 1038 1039 1040 1041 1042 1043 ... 1564